TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 53 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818,201 | +445.4% | 575,380 | +14.1% | 0.87% | +465.6% |
| Q2 2023 | $333,396 | +16.3% | 504,380 | +40.4% | 0.15% | -0.6% |
| Q1 2023 | $286,632 | -59.5% | 359,367 | +14.6% | 0.16% | -65.5% |
| Q4 2022 | $708,413 | +60.3% | 313,457 | +36.8% | 0.45% | +62.7% |
| Q3 2022 | $442,000 | -24.6% | 229,069 | +45.2% | 0.28% | -20.0% |
| Q2 2022 | $586,000 | -40.8% | 157,774 | +3.8% | 0.34% | -19.2% |
| Q1 2022 | $990,000 | -41.7% | 151,974 | +4.3% | 0.43% | -33.6% |
| Q4 2021 | $1,697,000 | – | 145,718 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |